Home/Filings/4/0000950170-25-113588
4//SEC Filing

JACOBS CINDY 4

Accession 0000950170-25-113588

CIK 0000949858other

Filed

Sep 7, 8:00 PM ET

Accepted

Sep 8, 4:51 PM ET

Size

12.4 KB

Accession

0000950170-25-113588

Insider Transaction Report

Form 4
Period: 2025-09-04
JACOBS CINDY
EVP, CMO
Transactions
  • Sale

    Common Stock

    2025-09-04$2.77/sh27,629$76,532115,585 total
  • Exercise/Conversion

    Performance Restricted Stock Unit (PRSU)

    2025-09-0484,0000 total
    Exp: 2028-01-22Common Stock (84,000 underlying)
  • Exercise/Conversion

    Common Stock

    2025-09-04+110,000143,214 total
  • Exercise/Conversion

    Performance Restricted Stock Unit (PRSU)

    2025-09-0426,000104,000 total
    Exp: 2035-01-28Common Stock (26,000 underlying)
Footnotes (8)
  • [F1]Represents shares of common stock acquired upon settlement of the performance restricted stock units ("PRSUs") listed in Table II.
  • [F2]Represents shares of common stock that have been sold by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the PRSUs.
  • [F3]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.68 to $2.88 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]Represents PRSUs previously reported on January 24, 2024 that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors.
  • [F5]Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement.
  • [F6]Pursuant to the terms of the award agreement governing the PRSU, the total number of shares underlying the PRSU vest on the achievement of one of certain milestones.
  • [F7]Represents PRSUs previously reported on January 30, 2025 that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors.
  • [F8]Pursuant to the terms of the award agreement governing the PRSU, the number of underlying shares of the Issuer's common stock that may ultimately vest ranges from 0% to 100% of the number of the PRSUs initially granted, subject to certain milestones being met during the measurement period.

Documents

1 file

Issuer

ACHIEVE LIFE SCIENCES, INC.

CIK 0000949858

Entity typeother

Related Parties

1
  • filerCIK 0001229762

Filing Metadata

Form type
4
Filed
Sep 7, 8:00 PM ET
Accepted
Sep 8, 4:51 PM ET
Size
12.4 KB